SARS-CoV-2 genetic variants identified in selected regions of Ethiopia through whole genome sequencing: Insights from the fifth wave of COVID-19
Authors:
- Mengistu LegesseMLMengistu Legesse
- Andargachew MuluAMAndargachew Mulu
- Girmay MedhinGMGirmay Medhin
- Mesfin MengeshaMMMesfin Mengesha
- Dawit HailuDHDawit Hailu
- Abaysew AyeleAAAbaysew Ayele
- Atsbeha GebreegziabxierAGAtsbeha Gebreegziabxier
- Adamu TayachewATAdamu Tayachew
- Adimkewu AguineAAAdimkewu Aguine
- Tessema Sofoniyas KTKTessema Sofoniyas K
- Harris OnyweraHOHarris Onywera
Preprint
- 15 November 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
Background: During the COVID-19 pandemic, global sequencing highlighted SARS-CoV-2 variants with increased transmissibility and immune evasion. In Ethiopia, where COVID-19 cases surged, little was known about the virus's dynamics. This study aimed to analyze SARS-CoV-2 variants during the fifth wave of the pandemic, crucial for vaccine, therapeutic, and diagnostic selection, as well as understanding of disease progression and severity. Method: From the samples collected from different parts of the country between June and August 2022, a total of 150 SARS-CoV-2 positive samples were randomly retrieved from the repository of the national SARS-CoV-2 reference laboratory of Ethiopian Public Health Institute (EPHI). Samples were re-analyzed using BIO-RAD, CFX96 Deep Well™ Real-Time PCR Detection system. Only 70 samples with a Ct value <30 were selected for next-generation sequencing using NextSeq 550 platform (Illumina platform). Out of 70, 63 genome sequences passed the bioinformatics quality and were chosen for further analysis. The genomic data was analyzed using bioinformatics and statistical tools. The reference genome "hCoV-19/Wuhan/WIV04/2019" was used for phylogeny. In addition, 117 sequence pairs were downloaded from GISAID, originating from 18 neighbouring countries and different parts of the world, in order to estimate the average evolutionary divergence across all sequence pairs. Results: Of the 63 genome sequences, 44 (69.8%) were from male and 19 (30.2%) were from Female. The median age of patient was 34 years. The dominant variant was Omicron (97%, 61/63), followed by Delta (3.2%, 2/63). Within Omicron, clade 22A was most prevalent (64%, 40/63), while other clades like 22B (18%, 11/63) and 21K (14%, 9/63) also present. Evolutionary divergence was limited, with Ethiopian sequences showing less genetic diversity compared to global sequences. Conclusion:The Omicron variant dominated the fifth wave in Ethiopia, with evidence of recent community transmission. Despite slight differences in genetic diversity with global sequences, the study underscores the importance of ongoing surveillance for variant tracking and public health interventions.Keywords
All Related Versions
Funding Information
- International Centre for Genetic Engineering and Biotechnology (NA)
This publication has 45 references indexed in Scilit:
- Long-term monitoring of SARS-CoV-2 seroprevalence and variants in Ethiopia provides prediction for immunity and cross-immunityNature Communications, 2024
- Seroepidemiology and model-based prediction of SARS-CoV-2 in Ethiopia: longitudinal cohort study among front-line hospital workers and communitiesThe Lancet Global Health, 2021
- Genomic characterization of SARS‐CoV‐2 isolates from patients in Turkey reveals the presence of novel mutations in spike and nsp12 proteinsJournal of Medical Virology, 2021
- What Are the Clinical Implications of the SARS-CoV-2 VariantsJACC: Basic To Translational Science, 2021
- A systematic review of asymptomatic infections with COVID-19Journal of Microbiology, Immunology and Infection, 2021
- Crystal structure of SARS-CoV-2 papain-like proteaseActa Pharmaceutica Sinica B, 2021
- The COVID-19 pandemic: Impacts on cities and major lessons for urban planning, design, and managementScience of The Total Environment, 2020
- Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19Acta Pharmacologica Sinica, 2020
- COVID-19: immunopathogenesis and ImmunotherapeuticsSignal Transduction and Targeted Therapy, 2020
- Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in ChinaCell Host & Microbe, 2020